WG
NBRV

Winton Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Winton Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-677
Closed -$23K – 1536
2021
Q2 		$23K Sell
677
-651
-49% -$24.2K ﹤0.01% 1407
2021
Q1 		$55K Buy
1,328
+274
+26% +$17K ﹤0.01% 1349
2020
Q4 		$64K Sell
1,054
-1,481
-58% -$160K ﹤0.01% 1281
2020
Q3 		$338K Buy
2,535
+1,064
+72% +$178K 0.01% 1210
2020
Q2 		$248K Buy
+1,471
New +$245K 0.01% 1320

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return

Winton Group's NBRV Position: Q3 2021 in Review

Winton Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2021, closing a stake of 677 shares — an estimated $23K sold.

Winton Group first reported a position in NBRV in Q2 2020 and held it in 5 quarters. The position peaked at $338K in Q3 2020. 31 funds tracked by Wall St. Rank hold NBRV as of Q3 2021.

  • Winton Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2021 after selling out during the quarter.
  • Winton Group sold 677 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2021, an estimated $23K.
  • Winton Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 5 quarters.
  • Winton Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $338K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2021.

Based on Winton Group's 13F filing for Q3 2021, filed 28 Oct 2021.